A, L., M, M., J, A., R, B., D, H., F, R., & F, V. (2015). Anticancer activity of halofuginone in a preclinical model of osteosarcoma: Inhibition of tumor growth and lung metastases. Oncotarget, 6(16), 14413. https://doi.org/10.18632/oncotarget.3891
Chicago Style (17th ed.) CitationA, Lamora, Mullard M, Amiaud J, Brion R, Heymann D, Redini F, and Verrecchia F. "Anticancer Activity of Halofuginone in a Preclinical Model of Osteosarcoma: Inhibition of Tumor Growth and Lung Metastases." Oncotarget 6, no. 16 (2015): 14413. https://doi.org/10.18632/oncotarget.3891.
MLA (9th ed.) CitationA, Lamora, et al. "Anticancer Activity of Halofuginone in a Preclinical Model of Osteosarcoma: Inhibition of Tumor Growth and Lung Metastases." Oncotarget, vol. 6, no. 16, 2015, p. 14413, https://doi.org/10.18632/oncotarget.3891.